In last trading session, Cognition Therapeutics Inc (NASDAQ:CGTX) saw 1.6 million shares changing hands with its beta currently measuring 1.01. Company’s recent per share price level of $0.42 trading at $0.01 or 3.82% at ring of the bell on the day assigns it a market valuation of $17.63M. That closing price of CGTX’s stock is at a discount of -602.38% from its 52-week high price of $2.95 and is indicating a premium of 19.05% from its 52-week low price of $0.34. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.98 million shares which gives us an average trading volume of 7.64 million if we extend that period to 3-months.

For Cognition Therapeutics Inc (CGTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.

Cognition Therapeutics Inc (NASDAQ:CGTX) trade information

Upright in the green during last session for gaining 3.82%, in the last five days CGTX remained trading in the red while hitting it’s week-highest on Thursday, 03/06/25 when the stock touched $0.42 price level, adding 6.02% to its value on the day. Cognition Therapeutics Inc’s shares saw a change of -39.50% in year-to-date performance and have moved -1.55% in past 5-day. Cognition Therapeutics Inc (NASDAQ:CGTX) showed a performance of -29.19% in past 30-days. Number of shares sold short was 2.11 million shares which calculate 0.8 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -21.09% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 4.46% while estimates for its earnings growth in next 5 years are of 9.38%.

Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders

Insiders are in possession of 3.34% of company’s total shares while institution are holding 26.67 percent of that, with stock having share float percentage of 27.59%. Investors also watch the number of corporate investors in a company very closely, which is 26.67% institutions for Cognition Therapeutics Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CGTX for having 1.15 million shares of worth $1.9 million. And as of 2024-06-30, it was holding 3.4016 of the company’s outstanding shares.

The second largest institutional holder is AWM INVESTMENT COMPANY, INC., which was holding about 0.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.6224 of outstanding shares, having a total worth of $1.08 million.